Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinoma

INTRODUCTION: The BRAF V600E mutation is the most common genetic event occurring in papillary thyroid cancer (PTC). Recently, the possibility of using immunohistochemistry (IHC) to detect the BRAF V600E mutation has been reported. MATERIALS AND METHODS: In 140 patients with classical PTC, the status...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Szymonek, Monika, Kowalik, Artur, Kopczyński, Janusz, Gąsior-Perczak, Danuta, Pałyga, Iwona, Walczyk, Agnieszka, Gadawska-Juszczyk, Klaudia, Płusa, Agnieszka, Mężyk, Ryszard, Chrapek, Magdalena, Góźdź, Stanisław, Kowalska, Aldona
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2017
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5650387/
https://ncbi.nlm.nih.gov/pubmed/29088832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20451
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares